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Effect of physical activity on heart rate variability in normal
weight, overweight and obese subjects: results from the
SAPALDIA study
Abstract
Many studies have demonstrated an association of both a sedentary lifestyle and a high body mass index
(BMI) with greater risk for cardiovascular disease. Within the prospective SAPALDIA cohort (Swiss
cohort Study on Air Pollution and Lung Diseases in Adults), we investigated whether regular exercise
was protective against reduced heart rate variability (HRV), a clinically relevant predictor of
cardiovascular morbidity and mortality, and whether adverse effects of obesity and weight gain on HRV
were modified by regular exercise. Twenty-four-hour electrocardiograms were recorded in 1,712
randomly selected SAPALDIA participants aged >or=50, for whom BMI was assessed in the years 1991
and 2001-2003. Other examinations included an interview investigating health status (especially
respiratory and cardiovascular health and health relevant behaviours including physical activity) and
measurements of blood pressure, body height and weight. The association between regular physical
activity and HRV and interactions with BMI and BMI change was assessed in multivariable linear
regression analyses. Compared to sedentary obese subjects, SDNN (standard deviation of all RR
intervals) was 14% (95% CI: 8-20%) higher in sedentary normal weight subjects; 19% (CI: 12-27%)
higher in normal weight subjects exercising regularly >or=2 h/week; and 19% (CI: 11-28%) higher in
obese subjects exercising regularly >or=2 h/week. Compared with sedentary subjects who gained
weight, those who gained weight but did exercise regularly had a 13% higher SDNN (CI: 7-20%).
Regular physical exercise has strong beneficial effects on cardiac autonomic nervous function and thus
appears to offset the negative effect of obesity on HRV.
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Abstract
Many studies have demonstrated an association of both a sedentary lifestyle and a high 
body mass index (BMI) with greater risk for cardiovascular disease. Within the prospective 
SAPALDIA cohort (Swiss cohort study on Air Pollution and Lung Diseases in Adults), we 
investigated whether regular exercise was protective against reduced heart rate variability 5
(HRV), a clinically relevant predictor of cardiovascular morbidity and mortality, and whether 
adverse effects of obesity and weight gain on HRV were modified by regular exercise.
24-hour electrocardiograms were recorded in 1712 randomly selected SAPALDIA 
participants aged ≥50, for whom BMI was assessed in 1991 and 2001-3. Other examinations 
included an interview investigating health status (especially respiratory and cardiovascular 10
health and health relevant behaviours including physical activity) and measurements of blood 
pressure, body height and weight. The association between regular physical activity and HRV 
and interactions with BMI and BMI change was assessed in multivariable linear regression 
analyses.
Compared to sedentary obese subjects, SDNN (standard deviation of all RR intervals) 15
was 14% (95% CI: 8-20%) higher in sedentary normal weight subjects; 19% (CI: 12-27%) 
higher in normal weight subjects exercising regularly ≥ 2h/week; and 19% (CI:11-28%) 
higher in obese subjects exercising regularly ≥ 2h/week.
Compared with sedentary subjects who gained weight, those who gained weight but 
did exercise regularly had a 13% higher SDNN (CI: 7-20%).20
Regular physical exercise has strong beneficial effects on cardiac autonomic nervous function 
and thus appears to offset the negative effect of obesity on HRV.
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Introduction
Obesity and weight gain are imposing a growing threat to world health, as in many 
countries 20-30% of adults are categorized as clinically obese, and their number is still 
increasing (World Health Organization 1999; World Health Organization 2002). Many 
studies have demonstrated an association of both a high body mass index (BMI) and a 5
sedentary lifestyle with greater risk for cardiovascular disease (Wei et al. 1999; Fang et al. 
2003).
In the SAPALDIA (Swiss cohort study on Air Pollution and Lung Diseases in Adults) 
study of a large sample of Swiss adults, we confirmed the relation of reduced heart rate 
variability (HRV) with increased BMI (Felber Dietrich et al. 2006). Heart rate variability 10
refers to the beat-to-beat variation in heart rate and is a marker of cardiac autonomic control 
(Kleiger et al. 2005). Reduced HRV predicts increased risk of cardiovascular disease and 
mortality in longitudinal studies (Kleiger et al. 1987; Bigger et al. 1993). Other studies have 
also noted that increased BMI is associated with reduced HRV, which has been attributed to 
decreased adreno-receptor responsiveness, withdrawal of parasympathetic tone and/or 15
increased sympathetic activity (Ramaekers et al. 1998; Fraley et al. 2005).
Within the prospective SAPALDIA cohort, we investigated whether regular exercise 
was associated with improved HRV, and whether adverse effects of obesity and weight gain 
on HRV were modified by regular exercise.
20
Methods
This study is part of the SAPALDIA cohort study, which was primarily designed to 
assess health effects from long-term exposure to air pollutants in the Swiss adult population. 
Details of its design and objectives have been reported elsewhere (Martin et al. 1997; 
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Ackermann-Liebrich et al. 2005). In brief, a random sample of the Swiss population was 
recruited in 1991 from eight areas featuring distinct geographical and environmental 
conditions. 9651 participants received intensive health examinations and a detailed health
interview in 1991. In 2001-2003, we were able to re-examine 8047 of the original participants 
and to assess HRV in a random selection (n=1846: 955 women, 891 men) of the 4417 5
participants aged ≥50 years by 24-hour ECGs. Exclusion criteria were general or spinal 
anaesthesia within eight days prior to the ambulatory ECG recording (n=5), having had a 
myocardial infarction within 3 months prior to the examination (n=2), and taking digitalis
(n=6); nobody had an artificial pacemaker. Exclusion of  recordings showing atrial fibrillation 
(n=12), recordings of <18h (recommendations of the Task Force of the European Society of 10
Cardiology and the North American Society of Pacing and Electrophysiology (North 
American Society of Pacing and Electrophysiology 1996)) (n=73), and recordings of 
insufficient quality (n=6) left 1742 datasets. We had complete information on 1718 subjects 
for analysis of HRV involving BMI and exercise and on 1712 subjects for analysis involving 
weight gain from baseline to follow-up. For statistical reasons, 15 subjects being underweight 15
at follow-up were excluded from analyses where BMI was used as a categorical variable, 
leaving 1703 records for analyses.
HRV measurements and analyses
For the Holter recording, digital devices (Aria, Del Mar Medical Systems, Irvine, CA, 
USA) with a frequency response of 0.05–40Hz and a resolution of 128 samples/s were used. 20
Three leads (V1, altered V3 with the electrode on the left midclavicular line on the lowest rib, 
and altered V5 with the electrode on the left anterior axillary line on the lowest rib) were 
recorded over 24 hours. The mean duration of the Holter recordings was 22.3 (SD 2.1) hours.
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All recordings were scanned through a StrataScan 563 (Del Mar) and interpreted using 
the interactive method, with a final visual check on the full disclosure. The length of each RR 
interval was manually validated during this step. Resampling was made at 4Hz. Spectral 
analysis was performed by the fast Fourier transform method. Only normal-to-normal 
intervals were used, with intervals excluded due to ectopy or artefacts being replaced by 5
holding the previous coupling interval level throughout the time interval to the next valid 
coupling interval. The standard deviation of all normal RR (NN) intervals (SDNN), which is a 
summary measure of HRV and the following frequency domain variables have been 
calculated: Total power (TP) (≤0.40 Hz), LF power (0.04–0.15Hz), high frequency (HF) 
power (0.15–0.40Hz) and the LF/HF ratio. HF power is an index of the parasympathetic 10
modulation of heart rate, whereas LF power is an index of the combined parasympathetic and 
sympathetic modulation of heart rate. LF/HF represents the sympatho-vagal balance (North 
American Society of Pacing and Electrophysiology 1996; Sztajzel 2004).
In order to avoid a biased result due to methacholine challenge, which was part of the 
SAPALDIA lung function testing and which, for practical reasons, was performed before the 15
Holter recording, we excluded the first two hours of all recordings.
Holter recordings were made between August 2001 and March 2003. Recorders were 
placed on participants having given consent after a detailed health interview. Participants were
asked to follow their regular daily routine and to complete a time-activity diary during the 
recording period.20
Other measurements
Body height and weight were measured with participants not wearing any shoes or 
coats and body mass index was calculated as weight [kg] divided by height squared [m2]. 
Four BMI groups were distinguished according to the WHO definitions (World Health 
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Organization 1999): underweight (< 18.5 kg/m2), normal weight (18.5-24.9 kg/m2), 
overweight (25.0-29.9 kg/m2) and obese (≥ 30kg/m2). In the 1991 cross-sectional study, body 
weight was asked. Weight gain was defined as being in a higher BMI category in the follow-
up study compared to the first survey.
The amount of physical activity (Question: 'How many hours a week do you usually 5
exercise such that you get out of breath or sweat?') (The European Community Respiratory 
Health Survey II 2000) and data on smoking, education, diabetes, level of daytime sleepiness 
(Epworth sleepiness scale) (Johns 1991; Johns 1993) and current medications status were 
assessed during a standardized interview which was led by trained fieldworkers. The 
participants were divided into tertiles of exercise: no regular physical exercise, ½ to 1 hour 10
and ≥ 2 hours of regular physical exercise.
Blood pressure was measured twice at rest in the sitting position on the left upper arm 
by an automatic device (705CP, OMRON, Tokyo, Japan) according to WHO 
recommendations (World Health Organization 1994). Blood pressure values used in the 
regression model were obtained by averaging the two measurements. Having high blood 15
pressure was defined as either having a systolic blood pressure > 140 mmHg, or a diastolic 
blood pressure > 90 mmHg, or having answered yes to the question "Do you have the 
following condition: Hypertension?".
The highest degree of education was used as a proxy for social position.
Blood samples were taken from the subjects and known cardiovascular risk factors 20
have been determined by the Institute for Clinical Chemistry of the University Hospital 
Zürich: A Hitachi Modular Autoanalyser (Rotkreuz, Switzerland) and assays from Roche 
Diagnostics (Mannheim, Germany) have been used to measure serum levels of uric acid, 
triglycerides and total cholesterol (all enzymatic tests). High sensitive C-reactive protein 
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(CRP) was measured using a latex-enhanced immunoturbidimetric assay. High-density 
lipoprotein cholesterol (HDL) was measured with a homogenous assay (Roche diagnostics, 
Mannheim, Germany) using Roche Cobas Integra (Rotkreuz, Switzerland). HDL values were 
only used if the participants had a triglyceride level of 9.4 mmol/l or lower. As additional 
atherogenic markers, the difference between total cholesterol and HDL (non-HDL-5
cholesterol) and the ratio between total cholesterol and HDL were calculated.
Ethical approval for the study was given by the central Ethics Committee of the Swiss 
Academy of Medical Sciences and the Cantonal Ethics Committees for each of the eight 
examination areas and subjects signed an informed consent at the examination.
Statistical methods10
Because an initial inspection suggested that the distribution of the residuals was 
skewed, the HRV-values were log-transformed for further analysis and the results are 
presented as percent difference between the exposure groups as well as geometric means.
To calculate the effect of BMI and physical activity on HRV, we used a multivariable 
regression model adjusting for study site, sex, age and age squared, education, self-reported 15
diabetes, hypertension, smoking status and beta-blocker intake in the previous 30 days.
We investigated modification of the effect of BMI by physical activity by introducing 
according interactions terms between exercise and BMI categories into the multivariable 
regression model.
Sensitivity analyses screening for additional potential confounders (Epworth 20
sleepiness score >10 vs ≤6; diuretics, sympathomimetics, calcium-channel blockers and 
angiotensin converting enzyme inhibitor intake during the previous 30 days; non-HDL-
cholesterol, uric acid and high sensitive CRP levels) were carried out.
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Statistical analyses were performed using Stata 9.2 (Stata corporation, College Station, 
Texas).
Results
Mean age of the population was 60 years (50-73 years). Baseline characteristics of the 5
1703 study participants by exercise category are given in Table 1. 37% of the study 
population were normal weight, 43% were overweight, and 20% obese, with a homogeneous 
distribution across exercise categories. Less than 1% of the study participants were morbidly 
obese. Between the first and the second survey, 35% had gained weight so that they changed 
into a higher BMI category. There was a higher proportion of women and current smokers in 10
the normal weight group, but fewer subjects with diabetes or subjects taking beta-blockers, 
diuretics or angiotensin converting enzyme (ACE) inhibitor. In that same group, subjects had 
lower average heart rate and systolic and diastolic blood pressure, and they were on average 
better educated and slightly younger; they also had lower levels of non-HDL-cholesterol, uric 
acid or C-reactive protein.15
Insert Table 1.
Table 2 exhibits the adjusted means of HRV parameters for different BMI and 
exercise categories. Within each BMI category, subjects regularly exercising ≥ 2 hours per 
week had higher HRV than sedentary subjects. Even obese subjects exercising ≥ 2 hours had 
a higher HRV than sedentary normal weight subjects.20
Insert Table 2.
Using a cubic model for BMI (continuous), subjects who exercise regularly had higher 
SDNN than their sedentary peers (online supplementary figure 1 showing curves of adjusted 
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geometric means for the three exercise categories). As can be deducted from these curves, 
SDNN in physically active subjects (≥ 2 hours of exercise per week) did not depend on BMI.
Figure 1 compares SDNN for obese subjects not exercising (reference group) to other 
BMI and exercise categories. Compared to obese subjects not exercising regularly, 
overweight subjects not exercising had an 11% [95% confidence interval (95% CI: 5 to 17%)] 5
higher SDNN and normal weight subjects not exercising had a 14% (95% CI: 8 to 20%) 
higher SDNN.
Regardless of weight, the improvement in SDNN was greatest for those who exercised 
regularly ≥ 2 hours per week. Compared to obese subjects not exercising, among those who 
exercised regularly, SDNN was 19% (95% CI: 12 to 27%) higher in normal weight subjects, 10
18% (95% CI: 12 to 26%) higher in overweight subjects, and 19% (95% CI: 11 to 28%) 
higher in obese subjects. The difference in SDNN within each BMI category between subjects 
exercising regularly ≥ 2 hours and sedentary subjects was highest in obese subjects. Regular 
exercise modified the relation of obesity with SDNN (95% CI: -0.214 to -0.036 for the 
difference in the effect of obesity compared to normal weight between subjects exercising 15
regularly (i.e., ≥ 2 hours) and subjects with a sedentary lifestyle) (online supplementary Table 
1).
Insert Figure 1.
Compared to sedentary obese subjects, obese subjects exercising regularly also had 
29% (95% CI: 9 to 53%) higher total power, 29% (95% CI: 0 to 66%) higher HF, 27% (95% 20
CI: 4 to 54%) higher LF (Figure 2) and a 2% (95% CI: -17 to 16%) lower LF/HF.
Insert Figure 2.
Next, we analysed the influence of weight gain between the first survey and the 
follow-up survey on HRV. Weight gain is defined as changing into a higher BMI category—
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e.g., becoming overweight or obese. Compared with subjects who gained weight and did not 
exercise regularly, those who gained weight but did exercise regularly had a 13% higher 
SDNN (95% CI: 7 to 20%), 16% higher total power (95% CI: 2 to 32%), 25% higher HF 
(95% CI: 3 to 52%), 24% higher LF (95% CI: 6 to 44%) and a 1% (95% CI: -14 to 12%) 
lower LF/HF (Figure 3).5
Insert Figure 3.
These associations were not due to a reduction in heart rate with exercise as there was 
no evidence for a change when heart rate was introduced into the models (Table 3). Mean 24-
hour heart rate in physically active was 74 bpm (95% CI: 72 to 76 bpm) as opposed to 76 bpm 
(95% CI: 74 to 77 bpm) in inactive obese.10
Sensitivity analyses
We tested the robustness of the results by including additional potential confounders 
into the model. Table 3 shows that daytime sleepiness, symptoms of chronic bronchitis, heart 
rate, cardioactive medication intake or cardiovascular risk markers in the blood did not 
sizeably change the effect estimates.15
We also evaluated whether daytime activity was responsible for HRV differences 
between populations with higher levels of exercise compared to populations with low levels 
of exercise. Although the estimates for the sleeping periods at night were different to the ones 
for the 24-hour periods, the relation between the different groups was similar to the one of the 
24-hour periods, which include active periods (online supplementary Table 2).20
Insert Table 3.
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Discussion
This study shows that middle-aged and elderly obese subjects who were regularly 
physically active had a higher HRV than their sedentary peers even after taking into account 
the effects of sex, age, study site, education, diabetes, hypertension, beta-blocker intake and 
smoking status. In addition, the improvement in HRV associated with exercise was similar for 5
obese and normal weight subjects. Thus, our data suggest that exercise improves autonomic 
function as measured by HRV. Analogously to the recently published results of Sui et al. of 
their study on cardiorespiratory fitness and adiposity as mortality predictors in older adults 
(Sui et al. 2007), we found that lower autonomic activity among inactive subjects was related 
to body fatness: inactive subjects who were normal weight had somewhat lower HRV than 10
normal weight exercising subjects, but higher than inactive obese subjects.
Several potential sources of bias were considered in this study. Smoking, diabetes or 
hypertension, all known to have an impact on HRV (Felber Dietrich et al. 2006), were 
controlled for in the baseline analysis. Obesity is also associated with obstructive sleep 
apnoea syndrome (OSAS) (Resta et al. 2001), which in turn, has a strong influence on the 15
autonomic nervous system (Narkiewicz and Somers 2003). Even more, obese patients with 
OSAS who loose weight experience an improvement in the severity of OSAS, as well as in 
blood pressure and cardiac autonomic regulation (Kansanen et al. 1998). We addressed this 
issue by additionally controlling for daytime sleepiness in sensitivity analyses but found no 
indication of such confounding. Furthermore, we were able to demonstrate that the observed 20
differences in HRV between groups were not caused by differences in health status 
represented by symptoms of chronic bronchitis, intake of cardioactive medication or 
cardiovascular risk markers in the blood.
Our findings are consistent with results from intervention trials comparing the 
beneficial effects of exercise and weight loss. Oberbach and colleagues have found that 25
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increases in adiponectin levels after four weeks of physical training disproportionally 
exceeded the beneficial effects of reduced percent body fat and increased fitness level 
(Oberbach et al. 2006). In other studies, three-month aerobic exercise intervention in 
overweight and obese subjects increased tissue-type plasminogen activator without evidence 
of changes in body mass or adiposity (Van Guilder et al. 2005), and 12 weeks of aerobic 5
training improved insulin sensitivity in overweight and obese girls without change in body 
weight, percent body fat and concentrations of inflammatory markers (Nassis et al. 2005).
There are several limitations of this study. One part of the study was cross-sectional in 
design - and hence causality cannot be inferred from existing associations. However, we were 
able to assess weight gain prospectively in the whole population and the fact that weight gain 10
is showing the same effect strengthens the argument for a causal relationship.
The data on physical activity were self-reported, as in most epidemiological studies 
(US Department of Health and Human Services 1996). Over-reporting of physical activity, 
the only conceivable form of reporting bias in this context, would have led to an 
underestimation of the effect size. Nonetheless, the physical activity questionnaire that we 15
used has been previously validated (Washburn et al. 1990) and used in other epidemiological 
studies. The comparative study concluded that self-reported sweat hours are suitable for 
distinguishing active from inactive subjects in epidemiological surveys. Our three activity 
categories allowed for such a distinction. In the European Community Respiratory Health 
Survey physical activity level assessed by the same tool was predictive of bronchial 20
hyperresponisiveness (Shaaban et al. 2007). Other studies have used other exercise categories; 
e.g. the Nurses Health Study used four categories from zero, moderate, to vigorous exercise, 
to ≥4 hours/week of vigorous exercise, showing that women who exercised ≥4 hours/week 
had a reduced risk for sudden cardiac death compared to those not being physically active 
(Whang et al. 2006). The Women's Health Study showed that even as little as 1 to 1.5 hours 25
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of light-to-moderate activity are associated with lower coronary heart disease rates (Lee et al. 
2001), which puts more emphasis on our results.
A given BMI may not correspond to the same degree of fatness in different people. In 
addition, the percentage of body fat mass is higher in women than in men for equivalent BMI 
(Ross et al. 1994). However, different studies have shown that BMI does sufficiently coincide 5
with the degree of body fatness when adjusting for age and sex (Gallagher et al. 1996; 
Movsesyan et al. 2003). Moreover, the discriminatory power for body fat and lean mass 
increases with the value of BMI and is high in obese people for which our results are most 
pronounced (Romero-Corral et al. 2006).
A major strength of the present study was the large number of participants. 10
Additionally, detailed information was available for numerous cardiovascular risk factors, 
allowing for control of potential confounders.
In conclusion, our results suggest that regular physical exercise has strong beneficial 
effects on cardiac autonomic nervous function, a clinically relevant predictor of 
cardiovascular morbidity and mortality and that exercise may offset the negative effect of 15
obesity.
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(exp), JM Tschopp (p), A von Eckardstein (cc), JP Zellweger (p), E Zemp Stutz (e).
Scientific team at coordinating centers: PO Bridevaux (p), I Curjuric (e), SH Downs (e/s), 
D Felber Dietrich (c), A Gemperli (s), D Keidel (s), M Imboden (g), P Staedele-Kessler (s), 
GA Thun (g)
(a) allergology, (c) cardiology, (cc) clinical chemistry, (e) epidemiology, (exp) exposure, (g) 
genetic and molecular biology, (m) meteorology, (p) pneumology, (s) statistics
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
References
Exercise and HRV   18
References
Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM et al (2005) Follow-up of the 
Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 
1991-2003: Methods and characterization of participants. Soz Praventivmed 50: 1-19
Bigger JT, Jr., Fleiss JL, Rolnitzky LM et al (1993) Frequency domain measures of heart 
period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 
21(3): 729-36
Fang J, Wylie-Rosett J, Cohen HW et al (2003) Exercise, body mass index, caloric intake, and 
cardiovascular mortality. Am J Prev Med 25(4): 283-9
Felber Dietrich D, Schindler C, Schwartz J et al (2006) Heart rate variability in an ageing 
population and its association with lifestyle and cardiovascular risk factors: results of 
the SAPALDIA study. Europace 8(7): 521-9
Fraley MA, Birchem JA, Senkottaiyan N et al (2005) Obesity and the electrocardiogram. 
Obes Rev 6(4): 275-81
Gallagher D, Visser M, Sepulveda D et al (1996) How useful is body mass index for 
comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 
143(3): 228-39
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness 
scale. Sleep 14(6): 540-5
Johns MW (1993) Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth 
Sleepiness Scale. Chest 103(1): 30-6
Kansanen M, Vanninen E, Tuunainen A et al (1998) The effect of a very low-calorie diet-
induced weight loss on the severity of obstructive sleep apnoea and autonomic 
nervous function in obese patients with obstructive sleep apnoea syndrome. Clin 
Physiol 18(4): 377-85
Kleiger RE, Miller JP, Bigger JT, Jr. et al (1987) Decreased heart rate variability and its 
association with increased mortality after acute myocardial infarction. Am J Cardiol 
59(4): 256-62
Kleiger RE, Stein PK and Bigger JT, Jr. (2005) Heart Rate Variability: Measurement and 
Clinical Utility. The Annals of Noninvasive Electrocardiography 10(1): 88-101
Lee IM, Rexrode KM, Cook NR et al (2001) Physical activity and coronary heart disease in 
women: is "no pain, no gain" passe? Jama 285(11): 1447-54
Martin BW, Ackermann-Liebrich U, Leuenberger P et al (1997) SAPALDIA: methods and 
participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung 
Diseases in Adults. Soz Praventivmed 42(2): 67-84
Movsesyan L, Tanko LB, Larsen PJ et al (2003) Variations in percentage of body fat within 
different BMI groups in young, middle-aged and old women. Clin Physiol Funct 
Imaging 23(3): 130-3
Narkiewicz K and Somers VK (2003) Sympathetic nerve activity in obstructive sleep apnoea. 
Acta Physiol Scand 177(3): 385-90
Nassis GP, Papantakou K, Skenderi K et al (2005) Aerobic exercise training improves insulin 
sensitivity without changes in body weight, body fat, adiponectin, and inflammatory 
markers in overweight and obese girls. Metabolism 54(11): 1472-9
North American Society of Pacing and Electrophysiology (1996) Heart rate variability: 
standards of measurement, physiological interpretation and clinical use. Task Force of 
the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology. Circulation 93(5): 1043-65
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
References
Exercise and HRV   19
Oberbach A, Tonjes A, Kloting N et al (2006) Effect of a 4 week physical training program 
on plasma concentrations of inflammatory markers in patients with abnormal glucose 
tolerance. Eur J Endocrinol 154(4): 577-85
Ramaekers D, Ector H, Aubert AE et al (1998) Heart rate variability and heart rate in healthy 
volunteers. Is the female autonomic nervous system cardioprotective? Eur Heart J 
19(9): 1334-41
Resta O, Foschino-Barbaro MP, Legari G et al (2001) Sleep-related breathing disorders, loud 
snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab 
Disord 25(5): 669-75
Romero-Corral A, Montori VM, Somers VK et al (2006) Association of bodyweight with 
total mortality and with cardiovascular events in coronary artery disease: a systematic 
review of cohort studies. Lancet 368(9536): 666-78
Ross R, Shaw KD, Rissanen J et al (1994) Sex differences in lean and adipose tissue 
distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin 
Nutr 59(6): 1277-85
Shaaban R, Leynaert B, Soussan D et al (2007) Physical activity and bronchial 
hyperresponsiveness: European Community Respiratory Health Survey II. Thorax 
62(5): 403-10
Sui X, LaMonte MJ, Laditka JN et al (2007) Cardiorespiratory fitness and adiposity as 
mortality predictors in older adults. Jama 298(21): 2507-16
Sztajzel J (2004) Heart rate variability: a noninvasive electrocardiographic method to measure 
the autonomic nervous system. Swiss Med Wkly 134(35-36): 514-22
The European Community Respiratory Health Survey II. (2000). "Main questionnaire."   
Retrieved 6 December, 2006, from 
http://www.ecrhs.org/Quests/ECRHSIImainquestionnaire.pdf.
US Department of Health and Human Services (1996) Physical activity and health, A report 
of the Surgeon General. CDC. Atlanta, US Department of Health and Human 
Services, Public Health Service, CDC.
Van Guilder GP, Hoetzer GL, Smith DT et al (2005) Endothelial t-PA release is impaired in 
overweight and obese adults but can be improved with regular aerobic exercise. Am J 
Physiol Endocrinol Metab 289(5): E807-13
Washburn RA, Goldfield SR, Smith KW et al (1990) The validity of self-reported exercise-
induced sweating as a measure of physical activity. Am J Epidemiol 132(1): 107-13
Wei M, Kampert JB, Barlow CE et al (1999) Relationship between low cardiorespiratory 
fitness and mortality in normal-weight, overweight, and obese men. Jama 282(16): 
1547-53
Whang W, Manson JE, Hu FB et al (2006) Physical exertion, exercise, and sudden cardiac 
death in women. Jama 295(12): 1399-403
World Health Organization (1994) WHO Expert Committee on Hypertension Control. 
Geneva.
World Health Organization (1999) Obesity: preventing and managing the global epidemic: 
report of a WHO consultation. WHO technical report series: 894. Geneva.
World Health Organization (2002) The European Health report 2002. WHO regional 
publications. European series; No. 97. Kopenhagen.
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Tables
Exercise and HRV   20
 Tables
Table 1 Baseline characteristics of the study population (n= 1703)
BMI normal weight overweight obese
n 636 (37%) 723 (43%) 344 (20%)
Female sex 400 (63%) 291 (40%) 180 (52%)
Current smokers 135 (21%) 139 (19%) 58 (17%)
Tertiary education 178 (28%) 189 (26%) 67 (20%)
Diabetes 10 (2%) 27 (4%) 34 (10%)
Beta-blocker intake 40 (6%) 88 (12%) 58 (17%)
Higher BMI cat. in follow-up 17 (3%) 348 (48%) 223 (65%)
no regular exercise 264 (42%) 295 (41%) 152 (44%)
½ - 1 h/week exercise 204 (32%) 243 (34%) 113 (33%)
≥2 h/week exercise 168 (26%) 185 (26%) 79 (23%)
Symptoms of chronic bronchitis 97 (15%) 115 (16%) 60 (17%)
Diuretic intake 8 (1%) 25 (4%) 27 (8%)
Sympathomimetic intake 11 (2%) 29 (4%) 13 (4%)
Calcium channel blocker 13 (2%) 37 (5%) 31 (9%)
ACE inhibitor intake 23 (4%) 49 (7%) 36 (11%)
Mean heart rate [bpm] 74 (SD 9.7) 74 (SD 9.0) 75 (SD 9.1)
Systolic blood pressure [mmHg] 125 (SD 19.0) 136 (SD 18.6) 138 (SD 17.0)
Diastolic blood pressure [mmHg] 78 (SD 10.2) 84 SD(10.1) 85 (SD 10.0)
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Age [years] 59.4 (SD 6.3) 60.8 (SD 6.2) 61.3 (SD 6.1)
Non-HDL cholesterol [mmol/L] 4.6 (SD 1.1) 4.9 (SD 1.2) 4.8 (SD 1.0)
Uric acid [μmol/L] 288.1 (SD 75.1) 341.8 (SD 79.9) 359.8 (SD 84.1)
C-reactive protein [mg/L] 1.9 (SD 4.5) 2.5 (SD 5.5) 3.9 (SD 5.5)
Epworth sleep score 6.3 (SD 3.6) 6.4 (SD 3.5) 7.0 (SD 3.8)
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Table 2 Adjusteda geometric mean (GM) of HRV in different exercise categories
BMI normal weight overweight obese
Exercise [h/week] GM 95% CI GM 95% CI GM 95% CI
None 131.8 (127.5, 136.3) 128.8 (124.9, 132.8) 115.9 (111.0, 121.1)
½ - 1 135.1 (130.2, 140.2) 131.3 (127.0, 135.8) 127.0 (120.9, 133.5)
SDNN [ms]
≥ 2 138.3 (132.8, 144.0) 137.3 (132.1, 142.8) 137.8 (129.9, 146.2)
None 3733.2 (3458.6, 4029.6) 3459.4 (3223.6, 3712.6) 3018.3 (2732.1, 3334.5)
½ - 1 3816.4 (3504.8, 4155.7) 3689.6 (3415.7, 3985.4) 3517.4 (3141.0, 3938.8)
Total power [ms2]
≥ 2 4081.3 (3717.0, 4481.4) 3725.3 (3407.3, 4072.9) 3904.0 (3410.0, 4469.7)
None 65.1 (58.0, 73.1) 68.6 (61.6, 76.3) 62.0 (53.3, 72.0)
½ - 1 67.1 (59.0, 76.3) 64.4 (57.4, 72.4) 71.0 (59.8, 84.2)
HF [ms2]
≥ 2 69.1 (60.0, 80.0) 77.1 (67.4, 88.2) 79.8 (65.1, 97.9)
None 206.6 (188.9, 225.9) 217.7 (200.4, 236.4) 167.4 (148.9, 188.1)
½ - 1 235.2 (212.9, 259.9) 223.2 (203.9, 244.3) 207.4 (181.6, 236.8)
LF [ms2]
≥ 2 247.4 (221.7, 276.0) 240.0 (216.2, 266.5) 211.9 (180.9, 248.4)
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None 3.2 (2.9, 3.4) 3.2 (3.0, 3.4) 2.8 (2.5, 3.1)
½ - 1 3.5 (3.2, 3.8) 3.5 (3.2, 3.8) 2.9 (2.6, 3.3)
LF/HF
≥ 2 3.6 (3.3, 3.9) 3.1 (2.8, 3.4) 2.7 (2.3, 3.0)
a adjusted for sex, age, age squared, study site, education, diabetes, hypertension, beta-blocker intake and smoking status
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Table 3 Sensitivity analyses adding different variables to the baseline model with the natural 
logarithm of SDNN as outcome variable
Effect estimatea 95% CI
Baseline analysis 19% 11-28%
+ Daytime sleepinessb 23% 12-35%
+ Symptoms of chronic bronchitisc 19% 10-28%
+ Heart rate 16%   9-24%
+Medicationd 19% 10-28%
+ Cardiovascular risk markers in the 
bloode
20% 11-29%
a Estimated %-increase in SDNN associated with regular physical (as compared to a sedentary 
way of life) exercise in obese, adjusted for sex, age, age squared, study site, education, 
diabetes, hypertension, beta-blocker intake and smoking status
b Epworth sleepiness score >10 vs. ≤6
c questionnaire data: "regular cough or phlegm, during the day or at night"
d diuretics, sympathomimetics, calcium channel blockers, angiotensin converting enzyme 
inhibitors
e non-HDL-cholesterol, uric acid, high sensitive c-reactive protein
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Titles and legends to figures
Exercise and HRV   25
Titles and legends to figures
Figure 1 compares SDNN for obese subjects not exercising (reference group) to other subject 
groups stratified by BMI category (normal, overweight, obese) and exercise status. Normal 
weight is defined as 18.5 ≤ BMI < 25.0 kg/m2; overweight 25.0 ≤ BMI < 30.0 kg/m2; obese 
30.0 ≤ BMI kg/m2). Effect estimates and 95% confidence intervals.
a Difference to sedentary obese subjects
b Difference to sedentary overweight subjects (95% CI: -0.196, -0.022)
c Difference to sedentary normal weight subjects (95% CI: -0.214, -0,036)
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Figure 2 Average percent increase and 95% confidence interval in measures of HRV (SDNN,
total power, HF, LF) in obese subjects exercising  2 h/week, compared to sedentary obese 
subjects.
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Figure 3 Average percent increase in measures of HRV (SDNN, total power, HF, LF) in 
subjects with weight gain exercising  2 h/week, compared to sedentary subjects with weight 
gain. Weight gain is defined as changing to a higher weight category (e.g., becoming 
overweight or obese)
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